secwatch.observer — SEC 8-K summary
======================================

Issuer:     OCULAR THERAPEUTIX, INC (OCUL)
CIK:        0001393434
Form:       8-K
Filed at:   2026-06-12T20:23:11+00:00
Accession:  0001104659-26-073496
Event type: leadership
Sentiment:  positive
Materiality: 0.65
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ocular Therapeutix appoints Jason Robins as permanent CFO; shareholders approve 10M share increase to stock plan
--------------------------------------------------------------------------------

- Jason Robins, interim CFO since Jan 2026, appointed permanent CFO; salary raised to $535,100 effective July 1, 2026, plus stock option and RSU grants.
- Shareholders approved Amendment No. 5 to 2021 Stock Incentive Plan, increasing shares by 10,000,000.
- Shareholders elected Pravin U. Dugel, M.D. and Merilee Raines as Class III directors for term until 2029.
- Advisory say-on-pay vote approved (116.1M for, 40.1M against); frequency set to 'One Year' (154.2M votes for one year).
- PricewaterhouseCoopers ratified as independent auditor for FY2026 (187.2M for, 2.1M against).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1393434/000110465926073496/0001104659-26-073496-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1393434/000110465926073496/tm2617802d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-073496

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer